Intellectual Property Magazine
Vital victory
ERS Genomicshas successfully defended one of its EU patents
Ben Wodecki
ERS Genomics has successfully defended one of its EU patentscovering CRISPR-Cas9 gene editing technologies, after the European
PatentOffice (EPO) rejected arguments filed in opposition to the patent.